Highlights,Institutional investors have adjusted their holdings in Unitil Co.,(NYSE:UTL),, reflecting recent market activity.

Filament Health Corp.  (NEO: FH) ("Filament" or the "Company"), a clinical?stage natural psychedelic drug development company, today announced positive data from an open-label phase 2 clinical trial ...

Kits Eyecare Ltd. ("KITS" or the "Company"), a leading vertically integrated eyecare provider, announces an upward revision to the Company's Q1 2025 Adjusted EBITDA guidance. The Company now expects ...